#JapanStocks

The year-end dividend for the fiscal year ending February 2026 is increased from 62.5 yen per share to 67.5 yen, resulting in an annual dividend of 110 yen and a consolidated payout ratio of 35.9%.

For the fiscal year ending February 2026, consolidated operating revenue was JPY 492,370 million (YoY -1.2%), and net income attributable to owners of the parent was a loss of JPY 8,194 million. For the fiscal year ending February 2027, operating revenue is projected at JPY 503,000 million (YoY +2.2%), with net income attributable to owners of the parent forecasted at...

For the fiscal year ending February 2026, consolidated revenue was 445,094 million yen (up 0.7% YoY), operating income was 49,015 million yen (down 15.8% YoY), and net income attributable to owners of parent was 28,282 million yen (down 31.7% YoY).

For the fiscal year ending February 2026, consolidated non-operating income of 1,821,795 thousand yen and extraordinary losses of 2,023,477 thousand yen were recorded. In standalone financials, special losses totaling approximately 4,031,393 thousand yen related to allowance for doubtful receivables from affiliated companies and others were recorded.

Consolidated sales for March 2026 increased 16.2% year-over-year to exceed 10 billion yen in a single month. All segments recorded significant sales growth: Laboratory +14.6%, Industry +18.1%, Medical +19.3%.

For the fiscal year ending February 2026, consolidated total operating revenue was 91,788 million yen (104.9% year-over-year), operating income was 46,683 million yen (118.6% year-over-year), and net income is unknown. The number of domestic stores was 1,793 (down 55 stores year-over-year).

In March 2027, total store sales increased 105.6% year-on-year, and existing stores rose 103.2%, supported by solid sales centered on spring merchandise. The 20% point-back campaign from March 17 to 30 contributed to sales growth.

As of April 2, 2026, there has been a change in the title and role of Executive Officer Hirohiko Shigemune, who has transitioned from Executive Vice President and Representative Director of Stylinglife Holdings Inc. to Executive Officer in charge of Corporate Special Missions at TBS Holdings, Inc.

Advantest Corporation will issue Euro Yen denominated convertible bonds with stock acquisition rights totaling 100 billion yen on April 1, 2026, to be allocated for strengthening semiconductor tester supply capacity, securing strategic inventory, and developing next-generation test solutions.

Closure of two local subsidiaries in Thailand effective April 30, 2026. The liquidation process is expected to take 1 to 2 years, with minimal impact anticipated on consolidated financial results.

Dear Life Co., Ltd. has acquired a 13-story reinforced concrete condominium located in Higashi-Nihonbashi, Chuo-ku, Tokyo, with a total floor area of 2,292.34 sqm. The acquisition price is undisclosed due to confidentiality obligations.

Announced the organizational restructuring of the Product Technology Institute and reorganization of the Automotive Business Headquarters effective April 1, 2026, along with multiple executive changes.